People gather at the gate of Changchun Changsheng Bio-technology Co Ltd, the Chinese vaccine maker, in Changchun, China July 26, 2018. REUTERS/Philip Wen
SHANGHAI/BEIJING: A Chinese vaccine scandal has laid bare a new challenge Beijing faces in its long-running battle for information control: blogs and online articles by independent writers capable of unleashing a storm of public fury.
The outrage over safety lapses by Changsheng Bio-technology Co Ltd in some of its vaccines for children came six days after the issue was flagged in regulatory filings, triggered instead by a July 21 article posted on the popular WeChat messaging platform.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
